BRIEF published on 10/15/2024 at 15:05, 1 year 5 months ago KindlyMD annonce un programme de rachat d'actions de 500 000 $ Rachat D'actions Valeur Actionnariale KindlyMD Conditions Du Marché Entreprise De Soins De Santé
BRIEF published on 10/15/2024 at 15:05, 1 year 5 months ago KindlyMD Announces $500,000 Stock Repurchase Program Shareholder Value Market Conditions Stock Repurchase Healthcare Company KindlyMD
PRESS RELEASE published on 10/15/2024 at 15:00, 1 year 5 months ago KindlyMD(TM) Announces $500,000 Share Repurchase Program KindlyMD, Inc. authorizes a $500,000 stock repurchase program, aiming to enhance shareholder value. The program may be made through various methods, considering market conditions Shareholder Value Stock Repurchase KindlyMD Patient-first Healthcare Integrated Therapies
BRIEF published on 10/08/2024 at 15:05, 1 year 6 months ago KindlyMD Secures Contract with UnitedHealthcare Healthcare Expansion Utah KindlyMD UnitedHealthcare Health Insurance
BRIEF published on 10/08/2024 at 15:05, 1 year 6 months ago KindlyMD signe un contrat avec UnitedHealthcare Utah Expansion Des Soins De Santé KindlyMD UnitedHealthcare Assurance Maladie
PRESS RELEASE published on 10/08/2024 at 15:00, 1 year 6 months ago KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States KindlyMD, Inc. announces its new contract with UnitedHealthcare Insurance, expanding coverage and access for patients in Utah, leading to potential revenue growth Utah Contract KindlyMD UnitedHealthcare Expanded Coverage
BRIEF published on 10/01/2024 at 15:05, 1 year 6 months ago KindlyMD(TM) to Participate in Upcoming October Conferences Medical Cannabis KindlyMD Tim Pickett Benzinga Conference LD Micro
BRIEF published on 10/01/2024 at 15:05, 1 year 6 months ago KindlyMD(TM) participera aux prochaines conférences d'octobre Cannabis Médical KindlyMD Tim Pickett LD Micro Conférence De Benzinga
PRESS RELEASE published on 10/01/2024 at 15:00, 1 year 6 months ago KindlyMD(TM) to Participate in Upcoming October Conferences KindlyMD, Inc. CEO to participate in investor conferences discussing medical cannabis experience best practices. Company integrates healthcare strategies with alternative therapies Investor Conferences Medical Cannabis KindlyMD Inc. Healthcare Data Alternative Therapies
BRIEF published on 09/12/2024 at 15:05, 1 year 6 months ago KindlyMD Recognized with Healthcare AI Impact Award 2024 AI Healthcare Medical Cannabis Awards Patient Data
Published on 04/10/2026 at 02:15, 7 hours 49 minutes ago Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Published on 04/10/2026 at 01:05, 8 hours 59 minutes ago Pathfinder Ventures Inc. Announces Tranche Closing of Financing and Extension of Private Placement
Published on 04/10/2026 at 00:00, 10 hours 4 minutes ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/09/2026 at 23:15, 10 hours 49 minutes ago Digi Power X Enters into Amended and Restated Sales Agreement
Published on 04/10/2026 at 09:44, 19 minutes ago Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Buy
Published on 04/10/2026 at 09:05, 59 minutes ago Award‑Nominated LENZING™ DualWipe Supports Europe’s Shift to Bio‑Based Materials
Published on 04/10/2026 at 09:00, 1 hour 4 minutes ago Expected decline in sales due to limited product availability
Published on 04/10/2026 at 10:00, 4 minutes ago Recticel Group akoestische materialen gebruikt in NASA’s Artemis II-missie
Published on 04/10/2026 at 10:00, 4 minutes ago Recticel Group’s acoustic materials used in NASA’s Artemis II-mission
Published on 04/10/2026 at 08:45, 1 hour 19 minutes ago Imerys-communique-presse-accord-ferme_10-04-2026_VFR
Published on 04/10/2026 at 08:45, 1 hour 19 minutes ago Imerys-press-release-binding-agreement_10-04-2026_VENG
Published on 04/10/2026 at 08:45, 1 hour 19 minutes ago BAIKOWSKI: 2025 annual results: Business growth and solid profitability including a non-recurring item
